All Stories

  1. Role of Fine Silica as Amorphous Solid Dispersion Carriers for Enhancing Drug Load and Preventing Recrystallization- A Comprehensive Review
  2. Biomedical Application of Chitosan and Chitosan Derivatives: A Comprehensive Review
  3. Research-based findings on scope of liposome-based cosmeceuticals: an updated review
  4. Self-emulsifying Drug Delivery System for Oral Anticancer Therapy: Constraints and Recent Development
  5. Biocompatible Supramolecular Mesoporous Silica Nanoparticles as the Next-Generation Drug Delivery System
  6. Amorphization of Drugs for Transdermal Delivery-a Recent Update
  7. Drug toxicity and forensic pharmacokinetics
  8. Transdermal Delivery of Macromolecules Using Nano Lipid Carriers
  9. Biopharmaceutical considerations in the pediatric and geriatric formulation development
  10. Pharmacokinetic characterization of drugs and new product development
  11. Cellulose-based nanomaterials in drug delivery applications
  12. Identifying underlying issues related to the inactive excipients of transfersomes based drug delivery system
  13. Reactive metabolites: Generation and estimation with electrochemistry based analytical strategy as an emerging screening tool
  14. Quantitation of Pregabalin by HPLC-UV Method using Ninhydrin derivatization: Development and Validation
  15. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization
  16. Core-shell structured pullulan based nanocomposites as erlotinib delivery shuttles
  17. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
  18. Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review
  19. Development and validation of a high throughput LC–MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study
  20. Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
  21. Stability-indicating RP-HPLC method for simultaneous quantitation of tramadol and aceclofenac in presence of their major degradation products: Method development and validation
  22. Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route
  23. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs
  24. Glidant effect of hydrophobic and hydrophilic nanosilica on a cohesive powder: Comparison of different flow characterization techniques
  25. Fast and simple gas chromatographic method for simultaneous estimation of camphor, menthol and methyl salicylate in analgesic ointment: application in stability study
  26. Advanced characterizations of nanoparticles for drug delivery: investigating their properties through the techniques used in their evaluations
  27. Mucoadhesive Polymers and Their Mode of Action: A Recent Update
  28. Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat
  29. Gastro-retentive drug delivery systems and their in vivo success: A recent update
  30. Self emulsifying drug delivery system
  31. Differential scanning calorimetric characterization of pharmaceutical powder blend uniformity in a laboratory-scale V-blender
  32. Binary carrier for solid dispersion
  33. Development and validation of an LC‐ESI‐MS/MS method for simultaneous quantitation of olmesartan and pioglitazone in rat plasma and its pharmacokinetic application
  34. Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant
  35. LC–MS–MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence Study
  36. LC–MS Simultaneous Determination of Itopride Hydrochloride and Domperidone in Human Plasma
  37. Rapid and Sensitive LC Method for the Analysis of Gemifloxacin in Human Plasma
  38. Determination of Drospirenone in Human Plasma by LC–Tandem-MS
  39. Extended Release Dosage Form of Glipizide: Development and Validation of a Level A in Vitro–in Vivo Correlation
  40. Optimization of Metformin HCl 500 mg Sustained Release Matrix Tablets Using Artificial Neural Network (ANN) Based on Multilayer Perceptrons (MLP) Model